These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4050)

  • 1. [3-(3-Isopropylamino-2-hydroxypropoxy)estra-1,3,5(10)-trien-17-one].
    Da Re P; Valenti P; Braga PC; Ferri S
    Arch Pharm (Weinheim); 1975 Dec; 308(12):981-2. PubMed ID: 4050
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses and beta-adrenergic blocking activities of the optical isomers of 8-acetonyloxyl-5-[3-(3,4-dimethoxyphenethylamino)-2-hydroxypropoxy]-3,4-dihydrocarbostyril.
    Yo E; Nakagawa K; Hoshino Y
    Chem Pharm Bull (Tokyo); 1981 Aug; 29(8):2157-60. PubMed ID: 6119164
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and pharmacological activity of some 1-alkylamino-3-(2'-methoxy-4'-diethylcarbamoyl-phenoxy)propan-2-ols.
    Monforte P; Basile M; Previtera T; Larizza A; Marmo E; De Gennaro G; Montinaro C; Filippelli W; Montanaro CS; Marfella A; Larizza D
    Farmaco Sci; 1983 Mar; 28(3):173-86. PubMed ID: 6133779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines.
    Meyer RF; Stratton CD; Hastings SG; Corey RM
    J Med Chem; 1973 Oct; 16(10):113-6. PubMed ID: 4147942
    [No Abstract]   [Full Text] [Related]  

  • 6. Nondepressant beta-adrenergic blocking agents. 1. Substituted 3-amino-1-(5,6,7,8-tetrahydro-1-naphthoxy)-2-propanols.
    Condon ME; Cimarusti CM; Fox R; Narayanan VL; Reid J; Sundeen JE; Hauck FP
    J Med Chem; 1978 Sep; 21(9):913-22. PubMed ID: 31485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a novel series of (aryloxy)propanolamines: new selective beta 2-blocking agents.
    Carre MC; Youlassani A; Caubere P; Saint-Aubin-Floch A; Blanc M; Advenier C
    J Med Chem; 1984 Jun; 27(6):792-9. PubMed ID: 6145801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and beta-adrenergic antagonist activity of novel (3-oxazolinyl-1,4-dihydropyridyl) propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1992 Jul; 8(4):265-72. PubMed ID: 1359908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.
    Hoefle ML; Hastings SG; Meyer RF; Corey RM; Holmes A; Stratton CD
    J Med Chem; 1975 Feb; 18(2):148-52. PubMed ID: 235644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivatives related to betaxolol with alpha- and beta-adrenergic activities.
    Leclerc G; Decker N; Schwartz J
    Arzneimittelforschung; 1985; 35(9):1357-67. PubMed ID: 2867769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic ethers of cyclohexylphenols with beta-blocking activity: synthesis and pharmacological study of exaprolol.
    Carissimi M; Gentili P; Grumelli E; Milla E; Picciola G; Ravenna F
    Arzneimittelforschung; 1976 Apr; 26(4):506-16. PubMed ID: 8056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [(Arylcarbonyl)oxy]propanolamines. 1. Novel beta-blockers with ultrashort duration of action.
    Kam ST; Matier WL; Mai KX; Barcelon-Yang C; Borgman RJ; O'Donnell JP; Stampfli HF; Sum CY; Anderson WG; Gorczynski RJ
    J Med Chem; 1984 Aug; 27(8):1007-16. PubMed ID: 6146718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenoceptor studies. 1. In vitro beta-adrenergic blocking, antiarrhythmic, and local anesthetic activities of a new series of aromatic bis(2-hydroxy-3-isopropylaminopropyl) ethers.
    Zaagsma J; Nauta WT
    J Med Chem; 1974 May; 17(5):507-13. PubMed ID: 4151492
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-adrenoceptor studies. 2. Effects of alkyl substitution on beta-adrenoceptor blocking, antiarrhythmic, and local anesthetic activities of 1,1'-(o-phenylenedioxy)bis(3-isopropylamino-2-propanol).
    Zaagsma J; Nauta WT
    J Med Chem; 1977 Apr; 20(4):527-31. PubMed ID: 15113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and adrenergic beta-blocking activity of some propanolamine derivatives.
    Obase H; Tatsuno H; Goto K; Shigenobu K; Kasuya Y; Yamada Y; Fujii K; Yada S
    Chem Pharm Bull (Tokyo); 1978 May; 26(5):1443-52. PubMed ID: 27307
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and irreversible beta-adrenergic blockade with a bromoacetamido derivative of betaxolol.
    Amlaiky N; Leclerc G
    J Pharm Sci; 1985 Oct; 74(10):1117-9. PubMed ID: 2867200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and beta-adrenergic antagonist activity of heterocyclic propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1993 Jun; 10(2):89-99. PubMed ID: 8104518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-short-acting beta-adrenergic receptor blocking agents. 2. (Aryloxy)propanolamines containing esters on the aryl function.
    Erhardt PW; Woo CM; Anderson WG; Gorczynski RJ
    J Med Chem; 1982 Dec; 25(12):1408-12. PubMed ID: 6130154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and beta-adrenergic blocking activity of oxipropanolamines of 3,4-dihydro-3-oxo-2H(1,4)benzothiazine.
    Cecchetti V; Fravolini A; Fringuelli R; Schiaffella F; Mascellani G; Pagella PG; Rugarli PL
    Farmaco Sci; 1987 Jan; 42(1):61-75. PubMed ID: 2898382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses and beta-adrenergic blocking activities of carbostyril derivatives.
    Tominaga M; Tone H; Nakagawa K; Takada K; Hoshino Y; Watanabe K
    Chem Pharm Bull (Tokyo); 1981 Aug; 29(8):2166-81. PubMed ID: 6119165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.